Sökning: onr:"swepub:oai:DiVA.org:umu-49358" >
Right ventricular l...
Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
-
- Rönn, Folke (författare)
- Umeå universitet,Kardiologi
-
- Kesek, Milos (författare)
- Umeå universitet,Kardiologi
-
- Karp, Kjell (författare)
- Umeå universitet,Klinisk fysiologi
-
visa fler...
-
- Henein, Michael (författare)
- Umeå universitet,Kardiologi
-
- Jensen, Steen M (författare)
- Umeå universitet,Kardiologi
-
visa färre...
-
(creator_code:org_t)
- 2011-06-28
- 2011
- Engelska.
-
Ingår i: Europace. - : Oxford University Press. - 1099-5129 .- 1532-2092. ; 13:12, s. 1747-1752
- Relaterad länk:
-
https://academic.oup...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aims Little is known about the optimal right ventricular (RV) pacing site in cardiac resynchronization therapy (CRT). This study compares bi-ventricular pacing at the left ventricular (LV) free wall combined with two different RV stimulation sites: RV outflow tract (RVOT+LV) vs. RV-apex (RVA+LV). Methods and results Thirty-three patients (32 males) with chronic heart failure, NYHA class III-IV, optimal drug therapy, QRS-duration ≥150 ms, and chronic atrial fibrillation (AF) received CRT with two different RV leads, in the apex (RVA) or outflow tract (RVOT), together with an LV lead, all connected to a bi-ventricular pacemaker. Randomization to pacing in RVOT+LV or RVA+LV was made 1 month after implantation and cross-over to the alternate pacing configuration occurred after 3 months. The median age of patients was 69 ± 10 years, the mean QRS was 179 ± 23 ms, and 58% of patients had ischaemic heart disease. Seven patients had pacemaker rhythm at inclusion and 60% were treated with atrioventricular-junctional ablation before randomization. In the RVA+LV and RVOT+LV pacing modes, 67 and 63% (nonsignificant) responded symptomatically with a decrease of at least 10 points in the Minnesota Living with Heart Failure score. The secondary end-points (6-min walk test, peak oxygen uptake, N-Terminal fragment of B-type Natriuretic Peptide, and left ventricular ejection fraction) showed significant improvement between baseline and CRT, but not between RVOT+LV and RVA+LV. Conclusion In this randomized controlled study, the exact RV pacing site, either apex or outflow tract, did not influence the benefits of CRT in a group of patients with chronic heart failure and AF. ClinicalTrials.gov ID: NCT00457834.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Congestive heart failure
- Cardiac resynchronization therapy
- Lead placement
- Atrial fibrillation
- Right ventricular pacing configurations
- Cardiac resynchronization
- Biventricular pacing
- Left ventricular pacing
- Right ventricular pacing
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Europace
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas